Policy

Is Fighting The Flu More Useful Than Preparing For Anthrax?

Published in Medical Letter on the CDC and FDA, February 24th, 2002

In 13,000 words on research priorities, the National Institutes of Health spanned the medical alphabet from arthritis to xeroderma pigmentosum. There was no mention of anthrax or bioterrorism.

That was in a booklet just 4 years ago. Today, the words are on everyone's lips, it seems. Federal agencies are pursuing research to counter bioterrorism with the same urgency - even abandon - that propelled the wars on cancer and AIDS.

In December, Congress for the first time pumped up annual funding for bioterrorism research to roughly $1 billion, according to an Associated Press estimate based on analysts' figures from the Office of Management and Budget...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-02-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry